NDUFV2

NDUFV2 encodes the 24-kDa iron-sulfur subunit of mitochondrial Complex I (NADH:ubiquinone oxidoreductase), carrying a single [2Fe-2S] (N1a) cluster and contributing to the catalytic core of the enzyme (PMID:7607668, PMID:7488192). The protein is imported into the mitochondrial matrix via an N-terminal targeting sequence (cleaved near residue 32) whose net positive charge and amphiphilic character are required for correct localization (PMID:21548921), and its mature stability depends on physical interaction with PHB2 (Prohibitin 2) (PMID:37451140). Beyond providing structural and catalytic function, NDUFV2 governs higher-order respiratory chain organization and mitochondrial ROS output: it regulates supercomplex assembly and, through ROS-dependent signaling, drives mitochondrial biogenesis (PMID:34697471). Complex I activity through NDUFV2 is acutely tunable by post-translational control, as Src-mediated phosphorylation of Tyr118 inhibits the enzyme and lowers mitochondrial superoxide generation (PMID:28219781). NDUFV2 transcription is directed by a housekeeping-type GC-box promoter activated by Sp1 (PMID:7488192, PMID:17786189), and its protein output is further constrained post-transcriptionally by the pseudogene NDUFV2P1, which limits NDUFV2 mRNA nuclear export by competing for NXF1 binding (PMID:42259816). Loss-of-function mutation — a splice-disrupting intron 2 deletion that reduces protein and impairs import — causes Complex I deficiency presenting as hypertrophic cardiomyopathy and encephalopathy (PMID:12754703, PMID:21548921). Through its control of OXPHOS capacity and ROS, NDUFV2 modulates cell fate and survival in cancer contexts, including drug-resistant tumor cell proliferation and macrophage polarization (PMID:42119952, PMID:41419454).

1. 1995 High

   Establishing the molecular identity of NDUFV2 defined it as the [2Fe-2S]-bearing 24-kDa subunit of Complex I and located the gene and its pseudogene in the genome.

   Evidence Molecular cloning, cDNA sequencing, and FISH chromosomal mapping

   PMID:7488192 PMID:7607668

   Open questions at the time

   • Does not localize the subunit within the Complex I module architecture
   • Functional role of the N1a cluster in electron transfer not addressed here
2. 1995 Medium

   Characterizing the promoter as TATA/CAAT-less with three GC boxes framed NDUFV2 as a housekeeping gene and predicted GC-box-dependent transcriptional control.

   Evidence DNA sequencing and promoter region analysis

   PMID:7488192

   Open questions at the time

   • Does not identify the transcription factors binding the GC boxes
   • No functional reporter validation in this study
3. 2003 High

   Identifying a homozygous splice-disrupting intron 2 deletion linked NDUFV2 loss-of-function directly to Complex I deficiency disease.

   Evidence DHPLC, sequencing, and protein quantification in patient-derived cells

   PMID:12754703

   Open questions at the time

   • Mechanism by which reduced protein impairs assembly not resolved here
   • Genotype-phenotype basis for variable presentation unaddressed
4. 2004 Medium

   A functional promoter SNP showed that NDUFV2 transcriptional output is genetically variable, providing a mechanistic anchor for disease association.

   Evidence Promoter reporter assay

   PMID:15450783

   Open questions at the time

   • Single functional assay, no endogenous expression validation
   • Causal contribution to phenotype not established
5. 2007 High

   Demonstrating that Sp1 binds the GC boxes and activates the promoter identified the transcription factor controlling NDUFV2 expression.

   Evidence Luciferase reporter, EMSA, and mithramycin inhibition in neuroblastoma cells

   PMID:17786189

   Open questions at the time

   • Other regulators acting on the promoter not excluded
   • Cell-type specificity of Sp1 dependence not characterized
6. 2011 High

   Mapping the mitochondrial targeting sequence explained how NDUFV2 reaches the matrix and why the disease deletion is pathogenic at the import level.

   Evidence Confocal imaging of tagged deletion/point mutants and site-directed mutagenesis in human cells

   PMID:21548921

   Open questions at the time

   • Import machinery (TOM/TIM) interactions not directly mapped
   • Processing protease cleaving near residue 32 not identified
7. 2017 High

   Identifying Src-dependent Tyr118 phosphorylation established a post-translational switch that negatively regulates Complex I and tunes mitochondrial ROS.

   Evidence LC-MS phosphoproteomics, Y118F mutagenesis, Complex I activity and ROS assays in H9c2 cells and perfused rat hearts

   PMID:28219781

   Open questions at the time

   • Structural basis for how Tyr118 phosphorylation inhibits catalysis not defined
   • Counteracting phosphatase not identified
8. 2018 Medium

   Correlating pseudogene expression inversely with NDUFV2 protein introduced post-transcriptional regulation by NDUFV2P1.

   Evidence Cell fractionation, protein quantification, and respiration measurement in schizophrenia-derived cells and postmortem brain

   PMID:30531937

   Open questions at the time

   • Correlative only, no direct manipulation in this study
   • Molecular mechanism of repression not yet defined
9. 2021 High

   Genetic mapping and overexpression revealed NDUFV2 as a controller of supercomplex assembly, ROS, and downstream mitochondrial biogenesis.

   Evidence Inbred-strain locus mapping, Ndufv2 overexpression, supercomplex assembly, ROS, and biogenesis assays in mice and humans

   PMID:34697471

   Open questions at the time

   • Mechanism linking ROS signal to biogenesis transcriptional program not detailed
   • Basis for sex- and tissue-specific gene regulation unresolved
10. 2023 High

    Identifying PHB2 as a physical partner that stabilizes NDUFV2 connected protein stability to Complex I integrity in stressed cardiomyocytes.

    Evidence Reciprocal Co-IP, pulldown, proteomics, and cardiac-specific PHB2 knockout mouse with functional assays

    PMID:37451140

    Open questions at the time

    • Whether PHB2 acts as a chaperone or assembly factor not distinguished
    • Stoichiometry and binding interface not mapped
11. 2025 Medium

    Loss-of-function in macrophages showed NDUFV2-driven OXPHOS suppresses ferroptosis and confers exosome-induced radioresistance, extending its role to immune cell metabolism.

    Evidence NDUFV2 knockdown, exosome co-culture, mitochondrial function readouts, and in vivo macrophage-depletion xenografts

    PMID:41419454

    Open questions at the time

    • Single lab; direct link between Complex I activity and ferroptosis pathway not dissected
    • Whether NDUFV2 acts upstream or downstream of polarization signals unclear
12. 2026 Medium

    Defining NXF1 competition by NDUFV2P1 provided the molecular mechanism for pseudogene-mediated suppression of NDUFV2 mRNA export.

    Evidence Subcellular fractionation, NXF1 RNA immunoprecipitation, NDUFV2P1 overexpression, and RBP interactome analysis

    PMID:42259816

    Open questions at the time

    • Single lab requiring further validation per authors
    • Identity of the cooperating RBPs not fully resolved
13. 2026 Medium

    Showing that SKQ1 binds NDUFV2 to trigger Complex I dysfunction and apoptosis established NDUFV2 as a druggable node for ROS-dependent tumor cell death.

    Evidence Direct binding assay, NDUFV2 knockout cells, ROS and apoptosis assays, and xenograft models

    PMID:42119952

    Open questions at the time

    • Binding site on NDUFV2 not mapped
    • Selectivity over other Complex I subunits not established

• How NDUFV2-dependent ROS signals are transduced into transcriptional programs for biogenesis and cell fate, and the structural basis of its regulatory phosphorylation and small-molecule binding, remain open.
• No structural model of NDUFV2 within human Complex I in the corpus
• Downstream effectors of ROS signaling unidentified
• Integration of transcriptional (Sp1), post-transcriptional (NDUFV2P1), and post-translational (Tyr118) layers not unified